Mark Tebbe

Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Nature 2019 Aug;572(7769):E18

IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.

View Article and Find Full Text PDF

August 2019

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Nature 2018 11 7;563(7732):564-568. Epub 2018 Nov 7.

IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.

View Article and Find Full Text PDF

November 2018

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

Authors:

Kyle W Sloop Francis S Willard Martin B Brenner James Ficorilli Kathleen Valasek Aaron D Showalter Thomas B Farb Julia X C Cao Amy L Cox M Dodson Michael Sonia Maria Gutierrez Sanfeliciano Mark J Tebbe Michael J Coghlan

Diabetes 2010 Dec 7;59(12):3099-107. Epub 2010 Sep 7.

Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.

View Article and Find Full Text PDF

December 2010

Structure activity studies of the serine-AIB dipeptide domain in 2,3-dihydroisothiazole based growth hormone secretagogues.

Authors:

Britta Evers Gerd Ruehter Martina Berg Jeffrey A Dodge Dirk Hankotius Ulrike Hary Louis N Jungheim Hans-Juergen Mest Eva-Maria Martin de la Nava Michael Mohr Brian S Muehl Soenke Petersen Birgit Sommer Grit Riedel-Herold Mark J Tebbe Kenneth J Thrasher Silke Voelkers

Bioorg Med Chem 2005 Dec 10;13(24):6748-62. Epub 2005 Oct 10.

Lilly Forschung GmbH, Division of Eli Lilly Research Laboratories, Essener Bogen 7, 22419 Hamburg, Germany.

View Article and Find Full Text PDF

December 2005

Discovery of a novel bicycloproline P2 bearing peptidyl alpha-ketoamide LY514962 as HCV protease inhibitor.

Authors:

Yvonne Yip Frantz Victor Jason Lamar Robert Johnson Q May Wang Donna Barket John Glass Ling Jin Lifei Liu Daryl Venable Mark Wakulchik Congping Xie Beverly Heinz Elcira Villarreal Joe Colacino Nathan Yumibe Mark Tebbe John Munroe Shu-Hui Chen

Bioorg Med Chem Lett 2004 Jan;14(1):251-6

Lilly Research Laboratory, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article and Find Full Text PDF

January 2004

4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity.

Authors:

Alfonso de Dios Lourdes Prieto Jose Alfredo Martín Almudena Rubio Jesus Ezquerra Mark Tebbe Beatriz López de Uralde Justina Martín Ana Sánchez Deborah L LeTourneau James E McGee Carole Boylan Thomas R Parr Michele C Smith

J Med Chem 2002 Sep;45(20):4559-70

Eli Lilly and Co., Lilly S.A., Avenida de la Industria, 30, 28108 Alcobendas, Madrid, Spain.

View Article and Find Full Text PDF

September 2002

Publications by authors named "Mark Tebbe"

Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Authors:

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Authors:

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

Authors:

Structure activity studies of the serine-AIB dipeptide domain in 2,3-dihydroisothiazole based growth hormone secretagogues.

Authors:

Discovery of a novel bicycloproline P2 bearing peptidyl alpha-ketoamide LY514962 as HCV protease inhibitor.

Authors:

4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity.

Authors: